ArticleNature communications2026
Creating highly active fluoroacetate dehalogenases via gate-based synergetic chain design.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Gate residues, acting in concert with distal dynamic networks, are emerging as critical yet underexploited regulators of enzymatic catalysis. Here we show that conformational dynamics analysis of fluoroacetate dehalogenase RPA1163 reveals a gate-based allosteric pair (K181-W185) that governs substrate access and reactivity. Network engineering of this pair yields a double mutant with high turnover number for α-fluorophenylpropionic acid (turnover number > 2 × 10⁵), establishing gate-centric allostery as a generalizable design principle. Structural and molecular dynamics analyses show that the activity enhancement arises from stabilization of catalytically competent open states through long-range coupling. Extension of this strategy to three additional dehalogenases confirms the universality of gate-based dynamic rewiring. Leveraging this framework, we establish a robust biocatalytic platform for stereoselective synthesis of α-fluoro and α-hydroxy carboxylic acids, achieving high productivity (turnover number > 3.7 × 10⁶) and enabling decagram-scale preparation of pharmaceutically relevant intermediates with high yield and enantioselectivity. Together, these findings establish gate-residue allostery as a powerful concept in protein engineering, bridging conformational dynamics with translational biocatalysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.